1. Home
  2. BOLT vs MHUA Comparison

BOLT vs MHUA Comparison

Compare BOLT & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • MHUA
  • Stock Information
  • Founded
  • BOLT 2015
  • MHUA 1990
  • Country
  • BOLT United States
  • MHUA China
  • Employees
  • BOLT N/A
  • MHUA N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • MHUA Medical Specialities
  • Sector
  • BOLT Health Care
  • MHUA Health Care
  • Exchange
  • BOLT Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • BOLT 16.8M
  • MHUA 19.6M
  • IPO Year
  • BOLT 2021
  • MHUA 2022
  • Fundamental
  • Price
  • BOLT $5.63
  • MHUA $0.42
  • Analyst Decision
  • BOLT Buy
  • MHUA
  • Analyst Count
  • BOLT 3
  • MHUA 0
  • Target Price
  • BOLT $50.00
  • MHUA N/A
  • AVG Volume (30 Days)
  • BOLT 19.4K
  • MHUA 102.1K
  • Earning Date
  • BOLT 08-12-2025
  • MHUA 04-25-2025
  • Dividend Yield
  • BOLT N/A
  • MHUA N/A
  • EPS Growth
  • BOLT N/A
  • MHUA N/A
  • EPS
  • BOLT N/A
  • MHUA 0.40
  • Revenue
  • BOLT $3,638,000.00
  • MHUA $96,909,642.00
  • Revenue This Year
  • BOLT N/A
  • MHUA N/A
  • Revenue Next Year
  • BOLT $24.14
  • MHUA N/A
  • P/E Ratio
  • BOLT N/A
  • MHUA $1.08
  • Revenue Growth
  • BOLT N/A
  • MHUA N/A
  • 52 Week Low
  • BOLT $5.20
  • MHUA $0.25
  • 52 Week High
  • BOLT $15.60
  • MHUA $1.47
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 43.75
  • MHUA 48.82
  • Support Level
  • BOLT $5.62
  • MHUA $0.41
  • Resistance Level
  • BOLT $6.40
  • MHUA $0.51
  • Average True Range (ATR)
  • BOLT 0.29
  • MHUA 0.05
  • MACD
  • BOLT 0.01
  • MHUA -0.00
  • Stochastic Oscillator
  • BOLT 25.00
  • MHUA 41.35

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: